can glutathione be given iv push 200 mg/ml (5 ML) - DORAL Glutathione IV Push in Boynton
Description
Data directionally consistent with Finnigan et al

Contemporary Issues in Exposure Assessment Using Biomonitoring

The combined clinical safety database from more than 20 clinical trials with tesofensine now contains approximately 1,600 patients taking a therapeutic dose for up to a year, providing robust safety data

Although a variant transketolase enzyme has been proposed to be associated with Wernicke-Korsakoff syndrome, no mutations have been found in the gene (symbol: TKT) encoding this enzyme when cloned from patients exhibiting the syndrome

Nakashima H

Abdollahi M